Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Myasthenia Gravis | Case report

Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report

Authors: Ruiqi Ma, Yun Cheng, Lu Gan, Xiaoting Zhou, Jiang Qian

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Coexistence of thyroid-associated ophthalmopathy (TAO) and ocular myasthenia gravis (OMG) is very rare. Little is known about the orbital histopathology associated with this condition. The authors reported a case of TAO coexisting with OMG and explored the histopathologic changes in extraocular muscles.

Case presentation

A 32-year-old man complaint of bilateral proptosis for 2 years. The patient was documented with a history of OMG and was treated with blepharoplasty to correct ptosis 3 years prior to presentation. Physical examination revealed right upper eyelid retraction resulting from the eyelid surgery. Computed tomographic scan demonstrated bilateral enlargement of the extraocular muscles. Thyroid function test confirmed hyperthyroid status. The patient was diagnosed with TAO (clinical activity score = 2/7) coexisting with OMG. Orbital decompression surgery reduced proptosis but resulted in new onset of left upper eyelid retraction because of the increased motor impulses to sustain eyelid elevation. Extraocular muscles were sampled during surgery and subjected to histopathologic stain. The stain results were analyzed against samples from age-, gender- matched TAO and control (non-TAO non-OMG) subjects. The measurement of myofiber size and glycosaminoglycan/collagen-occupied area was repeated in 3 randomly chosen fields of each slide. The variation of myofiber size was larger in the TAO + OMG (289.9 ± 142.5 μm2) samples than the TAO (544.1 ± 160.6 μm2) and control (157.0 ± 47.7 μm2) samples. Glycosaminoglycan was more abundant in the TAO + OMG (48.8 ± 12.2%) samples than the TAO (28.4 ± 3.6%) and control (3.3 ± 0.8%) samples. Collagen fibers accumulated in the TAO (60.5 ± 6.4%) samples but not in the TAO + OMG (36.1 ± 4.3%) and control (33.9 ± 2.7%) samples. Typical OMG changes were observed in the TAO + OMG samples but not in the TAO and control samples. These changes included central nuclei, aggregation of mitochondria and fiber type grouping. The histopathologic findings of TAO + OMG were summarized as inhomogeneously enlarged muscle fibers and predominantly endomysial accumulation of glycosaminoglycan.

Conclusion

This study highlights the possibility of TAO coexisting with OMG and demonstrates the histopathologic features in this rare condition.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S, et al. The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): review of the literature and report of a large series. Autoimmun Rev. 2019;18:287–92.CrossRef Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S, et al. The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): review of the literature and report of a large series. Autoimmun Rev. 2019;18:287–92.CrossRef
5.
go back to reference An R, Li Y, Yang BY, Wang H, Xu YM. Rare co-occurrence of ocular myasthenia gravis and thyroid-associated Orbitopathy (Ophthalmopathy) in an individual with hypothyroidism. Front Endocrinol. 2019;9:801.CrossRef An R, Li Y, Yang BY, Wang H, Xu YM. Rare co-occurrence of ocular myasthenia gravis and thyroid-associated Orbitopathy (Ophthalmopathy) in an individual with hypothyroidism. Front Endocrinol. 2019;9:801.CrossRef
6.
go back to reference Europa TA, Nel M, Heckmann JM. A review of the histopathological findings in myasthenia gravis: clues to the pathogenesis of treatment-resistance in extraocular muscles. Neuromuscul Disord. 2019;29:381–7.CrossRef Europa TA, Nel M, Heckmann JM. A review of the histopathological findings in myasthenia gravis: clues to the pathogenesis of treatment-resistance in extraocular muscles. Neuromuscul Disord. 2019;29:381–7.CrossRef
7.
go back to reference Rautenbach RM, Pillay K, Murray ADN, Heckmann JM. Extraocular muscle findings in myasthenia gravis associated treatment-resistant Ophthalmoplegia. J Neuroophthalmol. 2017;37:414–7.CrossRef Rautenbach RM, Pillay K, Murray ADN, Heckmann JM. Extraocular muscle findings in myasthenia gravis associated treatment-resistant Ophthalmoplegia. J Neuroophthalmol. 2017;37:414–7.CrossRef
8.
go back to reference Kumar S, Sharma VK. Unmasking ptosis in both eyes. N Engl J Med. 2017;377:e1.CrossRef Kumar S, Sharma VK. Unmasking ptosis in both eyes. N Engl J Med. 2017;377:e1.CrossRef
9.
go back to reference Chen YL, Yeh JH, Chiu HC. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand. 2013;127:170–4.CrossRef Chen YL, Yeh JH, Chiu HC. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand. 2013;127:170–4.CrossRef
10.
go back to reference Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15:82–92.CrossRef Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15:82–92.CrossRef
11.
go back to reference Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM, et al. New insights into the pathogenesis and nonsurgical management of graves orbitopathy. Nat Rev Endocrinol. 2020;16:104–16.CrossRef Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM, et al. New insights into the pathogenesis and nonsurgical management of graves orbitopathy. Nat Rev Endocrinol. 2020;16:104–16.CrossRef
12.
go back to reference Li Q, Ye H, Ding Y, Chen G, Liu Z, Xu J, et al. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS One. 2017;12:e0176064.CrossRef Li Q, Ye H, Ding Y, Chen G, Liu Z, Xu J, et al. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS One. 2017;12:e0176064.CrossRef
Metadata
Title
Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report
Authors
Ruiqi Ma
Yun Cheng
Lu Gan
Xiaoting Zhou
Jiang Qian
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01431-y

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue